Palatin Technologies, Inc.

PTN Healthcare Biotechnology

In the quarter to June 2026, revenue fell 14.1%, EPS fell 276.3% and free cash flow grew 34.2%, each against the same quarter a year earlier.

6.02 0.47 −7.24%
Market cap
$11.6M
P/E
0.0×
Fwd P/E
0.2×
Dividend yield
—
F-score
n/a
Altman Z
−67.72
Beneish M
n/a
Dividend safety
n/a
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17
Piotroski F-Score
— — 3 3 — — 2 3 — —
P/E ratio
0.00 — 0.00 0.00 0.00 0.00 0.00 6.41 8.06 0.00
P/S ratio
2.31 — 4.37 4.71 45.50 0.00 1.99 2.52 2.89 1.37
Altman Z-Score
(67.72) — (62.47) (37.09) (15.73) (3.06) 9.68 33.42 2.42 (7.81)
P/FCF ratio
0.00 — 0.00 0.00 0.00 0.00 2.91 0.00 115.53 6.21
Altman Z″-Score (non-manufacturers)
(176.87) — (148.08) (86.70) (37.69) (12.02) 9.33 24.59 (16.26) (21.61)
Beneish M-Score
— — — 0.65 — — — — — —
P/Operating CF
(11.34) — (4.22) (2.38) (8.66) (16.91) (19.75) (32.58) 18.50 (6.14)
P/B ratio
4.56 — 0.00 0.00 4.11 2.91 1.50 2.25 7.20 0.00
EV/Sales
1.75 — 2.87 2.48 25.54 (453.04) 0.64 2.04 2.33 0.78
EV/EBITDA
0.00 — 0.00 0.00 0.00 0.00 0.00 5.12 6.02 0.00
EV/FCF
(1.70) — (0.57) (0.41) (1.24) (3.77) 0.93 (8.39) 93.12 3.53
Current Ratio
4.61 0.36 1.01 1.08 2.13 6.27 21.28 24.94 3.58 1.03
Net Debt/EBITDA
0.87 0.15 0.43 0.34 0.82 1.78 3.48 (1.22) (1.45) 3.24
Debt/Equity
0.00 0.00 0.00 (0.02) 0.01 0.02 0.01 0.00 0.01 (1.22)
ROE
(877.59%) 708.07% 2,843.65% (336.46%) (109.83%) (51.76%) (24.82%) 56.11% 226.63% 117.20%
ROA
(142.11%) (247.08%) (207.35%) (89.01%) (70.04%) (44.10%) (23.63%) 49.77% 51.54% (39.39%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 39.17% 0.00% 0.00%
Return on Tangible Assets
(128.68%) 348.86% (5,942.47%) (1,282.23%) (191.77%) (60.55%) (28.10%) 35.64% 88.49% (734.88%)
Average Days of Receivables
8.33 0.00 0.00 219.27 442.42 (3,058.57) 0.00 364.79 0.00 123.37
Earnings Yield
(27.52%) — (111.83%) (102.35%) (54.86%) (22.95%) (17.65%) 15.60% 12.41% (20.93%)
Free Cash Flow Yield
(44.55%) — (115.41%) (129.89%) (45.18%) (15.69%) 34.37% (9.65%) 0.87% 16.10%
Free Cash Flow per Share
(4.81) (39.60) (107.16) (136.39) (158.12) (119.67) 219.84 (131.36) 10.60 86.55
Book value per Share
2.37 (8.88) (0.38) (9.09) 85.22 262.29 427.13 605.35 170.13 (35.06)
Free Cash Flow
(13.58) (21.31) (31.50) (29.71) (30.18) (22.65) 41.26 (21.82) 1.68 12.75
EV/EBIT
0.00 — 0.00 0.00 0.00 0.00 0.00 5.12 6.04 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 30 Sep 2026